tiprankstipranks
Newamsterdam Pharma Company N.V. (NAMS)
NASDAQ:NAMS
US Market
NAMS
NewAmsterdam Pharma Company
RESEARCH TOOLSreports
Want to see NAMS full AI Analyst Report?

NewAmsterdam Pharma Company (NAMS) Balance Sheet

251 Followers

NewAmsterdam Pharma Company Balance Sheet

NewAmsterdam Pharma Company's total assets for Q1 2026 were $732.64M, a decrease of -4.76% from the previous quarter. NAMS total liabilities were $67.42M for the fiscal quarter, a -21.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Assets
$ 769.28M$ 864.62M$ 347.10M$ 478.50M$ 67.99M
Total Liabilities
$ 85.85M$ 107.12M$ 58.70M$ 48.43M$ 11.36M
Total Equity Gross Minority
$ 683.43M$ 757.50M$ 288.39M$ 430.07M$ 56.63M
Other Metrics
Currency in USD

NewAmsterdam Pharma Company Debt to Assets